24/7 Customer Support

Viscosupplementation Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

Global Viscosupplementation Market: By Product Type (Single Injection, Three Injection, and Five Injection); End User (Hospitals, and Orthopedic Clinics/ASCs); Region—Market Size, Industry Dynamics, Opportunity Analysis, and Forecast for 2023–2030

  • Published Date: Feb-2023  |   Format: pdfpowerpointexcel  |  Report ID: AA0223363  | Delivery: 2 to 4 Hours


Single injection, three injection, and five injections are the major products and services under the viscosupplementation market that are expected to grow substantially in the future.

The main end users of viscosupplementation includes hospitals, and orthopaedic clinics/ASCs.

The main benefits of viscosupplementation includes benefits regarding pain and function associated with osteoarthritis, and also favourably alters the course of the disease, through quantitatively and qualitatively improving the joint cartilage.

The global viscosupplementation market is projected to grow at a CAGR of 8.4% during the forecast period 2023-2030 and is expected to reach US$ 8,958.9 million by 2030.

Factor such as rising prevalence of osteoarthritis worldwide, healthcare infrastructure growth installed base and rise in demand for the treatment procedures, surge in geriatric population and high prevalence of obesity drives the growth in the global viscosupplementation market over the forecast period.

The three-injection segment holds the largest CAGR in the global viscosupplementation market during the forecast period, 2023-2030.

High cost and adverse effect inhibit the growth of the viscosupplementation market during the forecast period, 2023-2030.

Asia Pacific holds the major share in term of revenue in the global viscosupplementation market in 2022.

Japan holds the major share in term of revenue in the Asia Pacific viscosupplementation market in 2022.

With the increasing geriatric population, the prevalence of osteoarthritis is expected to increase dramatically which provides a lucrative growth opportunity in the viscosupplementation market.

Product Type, End User and Country are the different segments in the global viscosupplementation market.

Sanofi, Zimmer Holdings Inc., Anika Therapeutics, Seikagaku Corporation, Fidia Farmaceutici S.p.A.,  LG Chem, and Ferring B.V., among others are the major key players in the global viscosupplementation market.